SMAD2 and lung carcinoma: High mobility group protein A2 (HMGA2) has been shown to promote lung cancer progression in mouse and human cells by competing with TGF-β type III receptor for the let-7 microRNA (miRNA) family [107], while decreased let-7g levels influence the TGF-β pathway by targeting TβR1 and SMAD2 gene expression [108].